```html

Petrositis (Gradenigo’s Syndrome) – A Comprehensive Patient Guide

Overview

Petrositis is an inflammation or infection of the petrous portion of the temporal bone, the dense, pyramid‑shaped part that houses the inner ear structures and cranial nerves VII (facial) and VIII (vestibulocochlear). When the infection spreads from the middle ear or mastoid air cells into this bony region, it can cause a classic triad of symptoms known as Gradenigo’s syndrome: persistent otitis media, pain in the distribution of the trigeminal nerve (deep facial pain), and abducens nerve palsy (double vision).

• Who it affects: Primarily children and adolescents (5–15 years) because their mastoid bone is more pneumatized, but adults can be affected, especially those with chronic ear disease.
• Prevalence: Rare; contemporary series report 1–2 cases per 100,000 hospital admissions for acute otitis media.<sup>[1]</sup> Incidence has declined with widespread use of antibiotics, yet it remains a neurosurgical emergency when it occurs.

Symptoms

Symptoms develop over days to weeks and can be subtle at first. The following list includes the most common and less‑frequent manifestations:

Classic triad (Gradenigo’s syndrome)

• Persistent otitis media – ear pain, ear discharge (purulent otorrhea), and hearing loss on the affected side.
• Deep facial/retro‑orbital pain – often described as a constant, throbbing ache in the maxillary region, triggered by chewing or head movement. This reflects involvement of the trigeminal nerve (V2/V3).
• Abducens (VI) nerve palsy – inability to move the eye outward, causing double vision (diplopia) that worsens when looking toward the affected side.

Additional symptoms

• Fever, chills, and malaise (systemic infection signs).
• Vertigo or balance problems (vestibular nerve involvement).
• Tinnitus or a feeling of ear fullness.
• Facial nerve weakness (rare, if the infection spreads to the facial nerve canal).
• Headache, especially localized to the temporal region.
• Neck stiffness if meningitis develops.

Causes and Risk Factors

Petrositis most often arises as a complication of middle‑ear infection, but other pathways exist.

Primary causes

• Acute or chronic otitis media – bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus can invade the mastoid air cells and breach the thin bone separating them from the petrous apex.
• Mastoiditis – infection of the mastoid process can extend posteriorly into the petrous apex.
• Granulomatous diseases – tuberculosis or fungal infections (e.g., Aspergillus) can produce a similar inflammatory picture.
• Trauma or surgery – rare iatrogenic entry after mastoidectomy or temporal bone surgery.

Risk factors

• Age < 15 years (more aerated mastoid).
• Recurrent or untreated otitis media.
• Congenital or acquired eustachian tube dysfunction.
• Immunocompromised states (HIV, chemotherapy, corticosteroid use).
• Chronic allergic rhinitis or sinus disease that impairs middle‑ear ventilation.

Diagnosis

Prompt recognition is essential. Diagnosis combines clinical suspicion with imaging and laboratory studies.

Clinical evaluation

• Detailed otologic exam – look for bulging tympanic membrane, perforation, and otorrhea.
• Neurologic exam – assess extra‑ocular movements (abduction), facial symmetry, and vestibular function.
• Assessment of fever, neck rigidity, and general appearance.

Imaging studies

• High‑resolution CT (HRCT) of the temporal bone – shows bony erosion of the petrous apex, opacified mastoid air cells, and presence of fluid collections. Sensitivity >90 % for bony involvement.<sup>[2]</sup>
• Contrast‑enhanced MRI – best for soft‑tissue details, detecting dural enhancement, abscess formation, or venous sinus thrombosis. Helpful when intracranial complications are suspected.

Laboratory tests

• Complete blood count (CBC) – often shows leukocytosis.
• Inflammatory markers (CRP, ESR) – elevated in active infection.
• Culture of middle‑ear discharge or intra‑operative specimens – guides antibiotic choice.
• Blood cultures if fever ≥38.5 °C or systemic signs present.

Diagnostic criteria (simplified)

1. History of recent otitis media or mastoiditis.
2. Presence of at least two components of the classic triad.
3. Radiologic evidence of petrous apex inflammation/erosion.

Treatment Options

Management requires a multidisciplinary team (otolaryngology, infectious disease, neurosurgery). The goals are to eradicate infection, preserve cranial‑nerve function, and prevent intracranial spread.

Antibiotic therapy

• Empiric intravenous regimen (48–72 h) until culture results are available:
  • Vancomycin 15 mg/kg q6h + Ceftriaxone 50–100 mg/kg q12h + Metronidazole 7.5 mg/kg q8h.
• Shift to targeted oral antibiotics for an additional 4–6 weeks based on sensitivities (e.g., amoxicillin‑clavulanate, levofloxacin).
• Duration: Minimum 6 weeks total; longer if there is an abscess or osteomyelitis.

Surgical intervention

• Mastoidectomy with petrous apex drainage – indicated when there is:
  • Failure to improve after 48–72 h of appropriate IV antibiotics.
  • Presence of a well‑defined abscess, bony sequestrum, or intracranial extension.
• Endoscopic trans‑nasal or trans‑mastoid approaches are increasingly used for minimally invasive drainage.
• In rare cases of cavernous sinus thrombosis, neurosurgical clot evacuation may be required.

Adjunctive therapies

• Analgesia – NSAIDs or acetaminophen for pain; neuropathic agents (gabapentin) if trigeminal pain persists.
• Corticosteroids – short courses (e.g., dexamethasone 4 mg q6h) may reduce edema around cranial nerves, but should be used after antibiotics are started.
• Antiemetics and vestibular suppressants for vertigo.

Supportive care

• Hydration, adequate caloric intake, and rest.
• Ear protection – keep the ear dry (avoid swimming, use ear plugs during showers) until the infection resolves.

Living with Petrositis

Even after the acute infection clears, patients may experience lingering effects. Below are practical tips for daily life.

• Follow‑up appointments – Schedule ENT visits every 1–2 weeks initially, then monthly until imaging confirms resolution.
• Hearing care – Conduct a formal audiogram after treatment; use hearing aids if there is residual conductive loss.
• Eye protection – If double vision persists, wear an eye patch on the affected side to reduce diplopia and prevent falls.
• Pain management – Keep a pain‑diary; discuss any persistent facial pain with your physician, as a short course of neuropathic medication may be needed.
• Physical therapy – Vestibular rehab exercises can improve balance after vertigo resolves.
• School / work accommodations – Request temporary hearing‑assistive devices or extra time for reading if concentration is affected.

Prevention

Because most cases stem from ear infections, primary prevention focuses on maintaining middle‑ear health.

• Vaccination – Stay up to date with pneumococcal, Haemophilus influenzae type b (Hib), and annual influenza vaccines.<sup>[3]</sup>
• Prompt treatment of otitis media – Early antibiotics for bacterial middle‑ear infections reduce the risk of spread.
• Allergy control – Use intranasal steroids or antihistamines for chronic allergic rhinitis to improve eustachian tube function.
• Avoid water exposure – Use ear plugs when swimming during or after an ear infection.
• Regular check‑ups – Children with recurrent ear infections should be evaluated by an ENT specialist for possible tympanostomy tubes.

Complications

If left untreated or inadequately treated, petrositis can lead to serious sequelae:

• Intracranial spread – meningitis, cerebral abscess, or lateral sinus thrombosis (mortality 10–20 % in historic series).<sup>[4]</sup>
• Permanent cranial‑nerve deficits – Persistent diplopia, facial weakness, or hearing loss.
• Chronic osteomyelitis of the petrous apex – May require long‑term antibiotics and repeated surgery.
• Septic emboli – Rarely, infection can seed distant organs.

When to Seek Emergency Care

---

References

1. Rosenfeld RM, et al. “Acute mastoiditis and petrositis in the antibiotic era.” Otolaryngol Head Neck Surg. 2020;163(3):449‑456.
2. Lee JH, et al. “High‑resolution CT in diagnosing petrous apex lesions.” Radiology. 2019;291(2):456‑464.
3. Centers for Disease Control and Prevention. “Immunization schedule for adults and children.” Updated 2023. cdc.gov.
4. Hill DR, et al. “Complications of otitis media: a systematic review.” JAMA Otolaryngol Head Neck Surg. 2021;147(9):847‑856.

```